United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 9, 2026 · Filed Apr 10, 2026

On Apr 9, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$577.89 for US$5.78M under a trading plan, leaving 18,876 shares. Filed Apr 10, 2026 (Form 4).

Sold
10,000 shares
Price
US$577.89 average (US$574.87 to US$582.30)
Value
US$5.78M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 9, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 9, 2026Common StockSale560US$574.8728,316Direct
Apr 9, 2026Common StockSale1,956US$575.5326,360Direct
Apr 9, 2026Common StockSale1,586US$576.6324,774Direct
Apr 9, 2026Common StockSale1,617US$577.7723,157Direct
Apr 9, 2026Common StockSale1,139US$578.5222,018Direct
Apr 9, 2026Common StockSale1,224US$579.7520,794Direct
Apr 9, 2026Common StockSale1,756US$580.6419,038Direct
Apr 9, 2026Common StockSale162US$582.3018,876Direct

Source

View original at SEC

Related